RecruitingNCT04439552

fMRI and IVCM Cornea Microscopy of CXL in Keratoconus

Neuroplasticity of Pain Pathways and Corneal Afferent Regeneration Following Corneal Crosslinking (CXL) in Keratoconus


Sponsor

Boston Children's Hospital

Enrollment

60 participants

Start Date

Oct 4, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Evaluation of neuroplasticity of pain pathways and corneal afferent nerve regeneration following corneal crosslinking (CXL) in keratoconus patients using fMRI and corneal In Vivo Confocal Microscopy (IVCM).


Eligibility

Min Age: 8 YearsMax Age: 35 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with cornea, cornea injury, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 8 Years to 35 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Boston Children's Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04439552


Related Trials